Search

everythinglearnresearchcommunity

for

Search:↓

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Stress hormones and autoimmune reactions can cause hair loss.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Machine learning and single-cell analysis improve understanding and treatment of wound healing.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Cannabinoids may help treat various skin conditions.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Stem cell therapy shows promise in improving burn wound healing.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.